Understanding GIP for Weight Loss: What the Research Says

Understanding GIP for Weight Loss: What the Research Says Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Understanding GIP for Weight Loss: What the Research Says. ... Take a breath, settle in, and let's walk through this together — clearly, calmly, and based on what the evidence actually shows. ... We'll touch on GIP Hormone, Tirzepatide, GLP-1 Agonists — especially as they apply to real people over forty. ... The surge in popularity of dual incretin therapies has brought Glucose-Dependent Insulinotropic Polypeptide (GIP) . into the spotlight. Once considered secondary to GLP-1, GIP is now recognized as a powerful partner in the fight against obesity. Understanding how GIP works reveals why medications like tirzepatide deliver superior weight-loss outcomes compared to GLP-1 agonists alone. ... GIP is secreted by K-cells in the small intestine shortly after nutrient ingestion. Its primary job is to stimulate insulin release from the pancreas, but only when blood glucose is elevated—hence its glucose-dependent nature. Beyond insulin, GIP influences lipid metabolism, promotes fat storage in adipose tissue under certain conditions, and modulates appetite centers in the brain. Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/understanding-gip-glucose-dependent-insulinotropic-polypeptide-for-weight-loss-what-the-research-says-3